The Saber-C AVIA system from Elevation Spine is now FDA-cleared, combining a porous 3D-printed titanium interbody with a zero-profile cervical fixation design.
A New Option for Anterior Cervical Fusion
Elevation Spine announced this month that its Saber-C AVIA system has received FDA 510(k) clearance, giving surgeons a new tool for anterior cervical discectomy and fusion procedures. The California company built the system around a porous 3D-printed titanium interbody paired with both spike and screw fixation options, all delivered in a single tray.
The implant uses a 55% porosity lattice architecture that is designed to mimic trabecular bone, the spongy structure found at the ends of long bones, in vertebrae, and in the pelvis. Elevation reports that preclinical data links the porous structure to bone ingrowth, which is critical for long-term stability after fusion surgery.
Why Zero-Profile Matters
Traditional anterior cervical plates sit on the front of the spine and can cause complications such as dysphagia, or difficulty swallowing, if they protrude or irritate nearby soft tissue. A zero-profile system keeps the fixation hardware closer to the disc space, which can reduce those risks while still providing the biomechanical stability surgeons expect from plating.
The Saber-C AVIA implant comes in 6 degree lordotic and 12 degree hyperlordotic options, with a large central graft window to help encourage fusion between vertebrae. Having both spike and screw fixation in the same tray gives surgical teams flexibility without switching instrument sets mid-case.
Designed for Speed and Feedback
Charlie Gilbride, CEO of Elevation Spine, said the design was shaped by direct conversations with surgeons who already use the Saber platform. That feedback led to purposeful instrumentation and refinements that build on the original system rather than starting over.
The company is positioning its size as an advantage. A smaller spinal device firm can iterate quickly and stay close to its surgeon network in ways that larger competitors often cannot. Whether that agility translates into market share will depend on how well the implant performs in real-world use, but the clearance clears the way for immediate commercial launch in the United States.
What Comes Next
FDA clearance is a milestone, not a finish line. Elevation Spine will now need to demonstrate that the Saber-C AVIA delivers reliable outcomes across a range of patients and surgical settings. For now, the system joins a growing list of 3D-printed spinal implants that use porous titanium lattices to encourage bone integration, a trend that has become one of the most established applications of additive manufacturing in medicine.
Comments (0)
No comments yet. Be the first!
Leave a Comment